Guidelines on Urological Infections
By M. Grabe, R. Bartoletti, T. Cai, B. Köves, P. Tenke, F. Wagenlehner, B. Wullt. 2009
912 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/bb0622f0c4fabec2e5636ced6b2693c78b5e4a1e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Bachmann
- C. Gratzke
- M. Oelke
- A. Descazeaud
- S. Madersbacher
- M. Drake
- C. Mamoulakis
- S. Gravas
Citations in the corpus
- International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. (2011, background): “(147 of 177 fosfomycin and 70 of 84 trimethoprim-treated women, respectively) at the early follow-up visit [34].”
- Clinical practice guidelines for antimicrobial prophylaxis in surgery. (2013, unknown): “Preoperative UTI, particularly if recurrent, is recognized as a highrisk factor for postoperative infection, which is typically treated before procedures and is a common exclusion criterion from studies of efficacy of antimicrobial prophylaxis in urologic procedures [817,826–828].”
- UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies (2017, background): “…100mg of Trimethoprim (TMP) once a day; 40/200mg TMP/sulfamethoxazole (co-trimoxazole) once a day or three times a week; 3 g of fosfomycin trometamol every 10 days and, during pregnancy, for example, 125–250mg of cephalexin or cefaclor 250mg once a day (Grabe et al., 2015; Giancola et al., 2017).”
- Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery (2013, unknown): “, a single dose or less than 24 h duration) in urologic procedures [658,817,818,823,824,826,831,832,834,836,846,853, 857,859,862,865,866].”
- EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. (2015, methodology): “Once abnormal findings have been diagnosed, further evaluation is recommended according to the standards provided in other EAU guidelines, such as those on non– muscle-invasive bladder cancer, muscle-invasive and metastatic bladder cancer, upper urinary tract urothelial cell carcinoma, primary ureth”